Early-onset Parkinson disease

Gene: ATP13A2

Green List (high evidence)

ATP13A2 (ATPase 13A2, Ensemblv115)
EnsemblGeneIds (GRCh38): ENSG00000159363
EnsemblGeneIds (GRCh37): ENSG00000159363
OMIM: 610513, ClinGen, DECIPHER
ATP13A2 is in 30 panels

1 review

Kaitlyn Dianna Weldon (University of Melbourne)

Green List (high evidence)

This is a well-established Parkinson's disease gene.
Created: 25 Aug 2023, 9:23 a.m. | Last Modified: 25 Aug 2023, 9:23 a.m.
Panel Version: 0.243

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
parkinsonism due to ATP13A2 deficiency MONDO:0017809

Publications

History Filter Activity

16 Feb 2024, Gel status: 3

Entity classified by Genomics England curator

Bryony Thompson (Royal Melbourne Hospital)

Gene: atp13a2 has been classified as Green List (High Evidence).

16 Feb 2024, Gel status: 3

Set Phenotypes

Bryony Thompson (Royal Melbourne Hospital)

Phenotypes for gene: ATP13A2 were changed from to parkinsonism due to ATP13A2 deficiency MONDO:0017809

16 Feb 2024, Gel status: 3

Set publications

Bryony Thompson (Royal Melbourne Hospital)

Publications for gene: ATP13A2 were set to

16 Feb 2024, Gel status: 3

Set mode of inheritance

Bryony Thompson (Royal Melbourne Hospital)

Mode of inheritance for gene: ATP13A2 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal

17 Nov 2019, Gel status: 3

Created, Added New Source, Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services)

gene: ATP13A2 was added gene: ATP13A2 was added to Early onset Parkinson disease_MelbourneGenomics_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services,Melbourne Genomics Health Alliance Complex Neurology Flagship Mode of inheritance for gene: ATP13A2 was set to Unknown